Debt (Details) |
1 Months Ended | 3 Months Ended | |||
|---|---|---|---|---|---|
|
Dec. 10, 2021
USD ($)
$ / shares
$ / item
shares
|
Sep. 23, 2022 |
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
|
|
| Debt (Details) [Line Items] | |||||
| Interest rate, percentage | 8.00% | ||||
| Fixed price of pe share (in Dollars per Item) | $ / item | 0.25 | ||||
| Common stock per share (in Dollars per share) | $ / shares | $ 0.2 | ||||
| Aggregate common Stock | $ 878,260 | ||||
| Warrants at issuance | $ 170,210 | ||||
| Risk-free interest rate | 1.25% | ||||
| Expected life | 5 years | ||||
| Expected volatility | 142.53% | ||||
| Dividend yield percent | 0.00% | ||||
| Gross proceeds | $ 1,000,000 | ||||
| Cash placement agent fees | 100,000 | ||||
| Legal fees | $ 15,192 | ||||
| Description of securities purchase agreement | On September 23, 2022, the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor, a Promissory Note (the “Promissory Note”) in the principal sum of $700,000.00, which amount is the $644,000 actual amount of the purchase price plus an original issue discount in the amount of $56,000. In connection with the issuance of the Promissory Note, the Company issued to the investor warrants to purchase 2,800,000 shares of common stock at an exercise price of $0.225, as well as returnable warrants (the “Returnable Warrants”), which may only be exercised in the event that the Company were to default on certain debt obligations, to purchase 7,000,000 shares of common stock at an exercise price of $0.30, in each case subject to adjustment. The Promissory Note may be converted into Company common stock in the event of an event of default under the Promissory Note by the Company. | ||||
| Returnable Warrants term | 5 years | ||||
| Exercise Price (in Dollars per share) | $ / shares | $ 0.3 | ||||
| Conversion price (in Dollars per share) | $ / shares | $ 0.1 | ||||
| Associated fees | $ 1,750 | ||||
| Prepayment | $ 750 | ||||
| Warrants description | Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted as a result of a financing event at a valuation below the exercise price in effect at the time. For example, as a result of the December 2021 Offering, which would allow the new noteholders to convert their debt to shares of common stock at an exercise price of $0.20/share, some of the $0.30 warrants outstanding in the table below had their exercise price reduced from $0.30 to $0.2919 which was further adjusted to $0.2752 prior to September 30, 2022 upon the occurrence of a further dilutive event. The result of the warrant exercise price downward adjustment on modification date was treated as a deemed dividend and fully amortized on the transaction date, and the Company recorded $91,375 to additional paid in capital and retained earnings on the Company’s balance sheets. In addition to the reduction in exercise price, there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase. | ||||
| Commission fees | $ 604,800 | ||||
| Placement Agent [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Aggregate common Stock | 878,260 | ||||
| Cash commission | 100,000 | ||||
| Promissory Notes [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Cash placement agent fees | 35,000 | ||||
| Legal fees | 7,000 | ||||
| Amortization expense | 4,976 | $ 0 | |||
| Debt discount | 341,094 | 0 | |||
| Interest expense | $ 1,400 | 0 | |||
| Warrants description | As a result of the financing, the Company is required to pay cash fees to its bankers (including the Placement Agent), which amounts are being determined but will not be less than $67,000, and to issue compensatory warrants to the Placement Agents to purchase 280,000 shares of common stock at an exercise price of $0.225, warrants to purchase 119,260 shares of common stock at an exercise price of $0.27, in each case subject to adjustment. | ||||
| Commission fees | $ 32,200 | ||||
| convertible promissory note and a security purchase agreement [Member] | Transaction Documents [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Issued warrants (in Shares) | shares | 5,434,783 | ||||
| Convertible Notes Payable [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Fixed price of pe share (in Dollars per Item) | $ / item | 0.2 | ||||
| Amortization expense | $ 539,570 | 0 | |||
| Debt discount | 420,627 | $ 960,197 | |||
| Interest expense | $ 21,546 | $ 0 | |||
| Convertible Notes Payable [Member] | convertible promissory note and a security purchase agreement [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Principal amount of discount | $ 1,086,956.52 | ||||
| Original issue discount | $ 1,000,000 | ||||
| Original discount, percentage | 8.00% | ||||
| Purchase of warrant (in Shares) | shares | 4,000,000 | ||||
| Notes payable interest rate | 8.00% | ||||
| Net proceeds amount | $ 500,000 | ||||
| Maturity date | Dec. 10, 2022 | ||||
| Convertible Notes Payable [Member] | convertible promissory note and a security purchase agreement [Member] | Common Stock [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Warrant exercisable price (in Dollars per share) | $ / shares | $ 0.25 | ||||
| Convertible Notes Payable [Member] | convertible promissory note and a security purchase agreement [Member] | Minimum [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Notes payable interest rate | 115.00% | ||||
| Convertible Notes Payable [Member] | convertible promissory note and a security purchase agreement [Member] | Maximum [Member] | |||||
| Debt (Details) [Line Items] | |||||
| Notes payable interest rate | 120.00% | ||||